To identify reasons for the underreporting of adverse drug reactions (ADRs) to the Belgian Centre for Pharmacovigilance.
Postal questionnaire to a random sample of 400 physicians selected among all Belgian physicians (Sample 1) and to a random sample 100 physicians among those having reported at least one ADR from September 1,1994 to April 30,1995 (Sample 2).
Comparison is made to a similar survey carried out in the UK.
Physicians'understanding of the role, objectives and functioning of the reporting system, and their attitudes and practice when faced with ADRs.
The response rate was 58.8% from Sample 1 and 95.0% from Sample 2. Of physicians in Sample 1,77%, 8% and 15% respectively had reported to the drug manufacturer only, the Belgian centre only or both.
Lack of forms when needed (40%), too busy timetable (27%) and ignorance of how to report (22%). More than 11% of all respondants believed that only safe drugs are marketed.
Although the objectives of the pharmacovigilance system are in general well understood, only 55% of physicians knew that reactions to vaccines should be reported.
There is a need for more adequate training and continuous education of medical students and health professionals as regards the objectives and scope of pharmacovigilance in Belgium.
Mots-clés Pascal : Pharmacovigilance, Toxicité, Médicament, Médecin, Personnel sanitaire, Homme, Enquête, Attitude, Comportement, Rôle professionnel, Belgique, Europe, Déclaration
Mots-clés Pascal anglais : Pharmacovigilance, Toxicity, Drug, Physician, Health staff, Human, Survey, Attitude, Behavior, Occupational role, Belgium, Europe
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 97-0058527
Code Inist : 002B02A06. Création : 21/05/1997.